We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+7.79%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$22.4B
AUM Growth
+$2.11B
Cap. Flow
+$775M
Cap. Flow %
3.46%
Top 10 Hldgs %
20.85%
Holding
3,349
New
266
Increased
1,598
Reduced
1,206
Closed
184

Sector Composition

Rank Sector Weight
1 Technology 10.23%
2 Consumer Discretionary 4.98%
3 Financials 4.7%
4 Healthcare 3.82%
5 Communication Services 3.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATHX
3051
DELISTED
Athersys, Inc. Common Stock
ATHX
$81K ﹤0.01%
3,601
PR
3052
Permian Resources
PR
$17.7B
$80K ﹤0.01%
13,345
-7,000
-34% -$47.7K
MIN
3053
Aberdeen Intermediate Income Fund
MIN
$280M
$79K ﹤0.01%
21,868
-64,022
-75% -$231K
ENDP
3054
DELISTED
Endo International plc
ENDP
$79K ﹤0.01%
20,880
+2,475
+13% +$12K
ANY icon
3055
Sphere 3D
ANY
$18M
$78K ﹤0.01%
+355
New +$138K
HYRE
3056
DELISTED
HyreCar Inc. Common Stock
HYRE
$76K ﹤0.01%
+16,180
New +$101K
WATT icon
3057
Energous
WATT
$82M
$74K ﹤0.01%
98
ABEV icon
3058
Ambev
ABEV
$43.8B
$73K ﹤0.01%
26,004
-2,175
-8% -$6.23K
SOLO
3059
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
$73K ﹤0.01%
32,166
-900
-3% -$2.85K
CIK
3060
Credit Suisse Asset Management Income Fund
CIK
$134M
$72K ﹤0.01%
+21,000
New +$72.4K
LIDR icon
3061
AEye
LIDR
$59.5M
$72K ﹤0.01%
+498
New +$76.7K
CRBP icon
3062
Corbus Pharmaceuticals
CRBP
$195M
$71K ﹤0.01%
3,864
+833
+27% +$22.6K
RDHL
3063
Redhill Biopharma
RDHL
$3.62M
$71K ﹤0.01%
+28
New +$112K
SCPX
3064
DELISTED
Scorpius Holdings, Inc.
SCPX
$71K ﹤0.01%
6
-4
-40% -$76.8K
HIO
3065
Western Asset High Income Opportunity Fund
HIO
$338M
$70K ﹤0.01%
13,493
+5
+0% +$26
RNXT icon
3066
RenovoRx
RNXT
$56.8M
$70K ﹤0.01%
14,400
-26,450
-65% -$157K
SACH
3067
Sachem Capital Corp
SACH
$37.6M
$69K ﹤0.01%
+11,803
New +$68K
BFX
3068
DELISTED
BowFlex Inc.
BFX
$68K ﹤0.01%
11,058
-6,525
-37% -$54.1K
MUFG icon
3069
Mitsubishi UFJ Financial
MUFG
$260B
$67K ﹤0.01%
+12,342
New +$69.5K
OCGN icon
3070
Ocugen
OCGN
$458M
$67K ﹤0.01%
14,736
-1,885
-11% -$14.2K
SID icon
3071
Companhia Siderúrgica Nacional
SID
$1.19B
$67K ﹤0.01%
15,040
+3,285
+28% +$14.3K
USOI icon
3072
Credit Suisse AG Credit Suisse X-Links Crude Oil Shares Covered Call ETN
USOI
$42M
$64K ﹤0.01%
615
-32
-5% -$3.41K
WPRT
3073
Westport Fuel Systems
WPRT
$32.7M
$64K ﹤0.01%
2,689
-143
-5% -$4.08K
XELA
3074
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$64K ﹤0.01%
18
-5
-22% -$29.4K
EXPR
3075
DELISTED
Express, Inc.
EXPR
$63K ﹤0.01%
+1,015
New +$79.8K

Similar funds

Cambridge Investment Research Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Cambridge Investment Research Advisors held 3,349 positions worth $22.4B, up 10% from $20.3B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Cambridge Investment Research Advisors deployed $775M of net new capital in Q4 2021, opening 266 new positions and adding to 1,598 existing holdings. Its largest new stake was CION Investment: 424,367 shares worth $5.55M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.6% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $19.5M trimmed.

  • Cambridge Investment Research Advisors's largest Q4 2021 buy was CION Investment: 424,367 shares worth $5.55M.
  • Cambridge Investment Research Advisors added most to Invesco QQQ Trust in Q4 2021, an estimated $88.6M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $19.5M.
  • Cambridge Investment Research Advisors fully exited VEREIT, Inc. in Q4 2021, selling an estimated $5.14M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 21% of its $22.4B portfolio in Q4 2021.
  • Cambridge Investment Research Advisors opened 266 new positions and closed 184 in Q4 2021.
  • Cambridge Investment Research Advisors's portfolio value rose 10% quarter-over-quarter to $22.4B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.